Health Co. Execs Convicted In $100M Adderall Sales Scheme

A San Francisco federal jury weighing a first-of-its-kind case on Tuesday convicted two digital healthcare company executives of scheming to sell Adderall through deceptive advertising, allegedly bringing in $100 million in...

Already a subscriber? Click here to view full article